Parmax Pharma Ltd.
Search Company
  You can view the Income statement for the last 5 years.
ISIN No INE240T01014 52Wk High (Rs.) 55 BV (Rs.) -7.21 FV (Rs.) 10.00
Bookclosure 30/09/2024 52Wk Low (Rs.) 28 EPS (Rs.) 0.00 P/E (X) 0.00
Mkt Cap. (Rs. Cr.) 13.09 P/BV (X) -4.85 Div Yield (%) 0.00 Mkt Lot 1
 
(Rs. in Crs.)
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Net Sales/Income from operations28.2011.0515.4218.2526.20
Total Income From Operations28.2011.0515.4218.2526.20
      
EXPENDITURE     
Consumption of Raw Materials21.547.035.516.7213.41
Increase/Decrease in Stocks0.000.02-0.02-0.010.02
Employees Cost2.992.912.803.463.54
Depreciation1.031.711.881.931.94
Other Expenses3.434.464.885.525.82
Total Expenses28.9816.1415.0517.6224.73
      
P/L Before Other Inc. , Int., Excpt. Items & Tax-0.78-5.080.380.631.47
Other Income0.040.050.040.060.09
P/L Before Interest, Excpt. Items & Tax-0.74-5.030.420.691.56
Interest0.590.620.370.390.35
P/L Before Exceptional Items & Tax-1.32-5.660.050.301.21
Exceptional Items-1.070.000.000.000.00
P/L Before Tax-2.40-5.660.050.301.21
Tax-0.300.090.150.160.45
P/L After Tax from Ordinary Activities-2.09-5.75-0.100.140.75
Net Profit/Loss For the Period-2.09-5.75-0.100.140.75
      
Equity Share Capital3.743.743.743.743.74
Reserves And Surplus-6.44-4.381.401.511.37
EPS Before Extra Ordinary *     
Basic EPS (Rs.)-5.60-15.37-0.280.382.02
Diluted EPS (Rs.)-5.60-15.37-0.280.382.02
EPS After Extra Ordinary *     
Basic EPS (Rs.) -5.60-15.37-0.280.382.02
Diluted EPS (Rs.) -5.60-15.37-0.280.382.02
      
PBITOE Margin (%)-2.75-45.982.433.435.62
PBTE Margin (%)-4.69-51.170.291.664.61
PBT Margin (%)-8.49-51.170.291.664.61
PAT Margin (%)-7.42-52.02-0.670.772.87